The document is an intimation of BHEL's participation in Analyst/Institutional Investor meetings, classified as a regulatory disclosure.
The company will participate in two separate meetings on November 4, 2026:
A one-to-one meeting scheduled for 9:00 hrs (physical mode in Mumbai).
A group meeting scheduled for 17:00 hrs (physical mode in Mumbai).
The stated purpose of these meetings is to meet with investors.
The company explicitly stated that it will not make any presentation during these meetings.
The company confirmed it will be referring only to publicly available documents/information during the meets.
The disclosure includes compliance language indicating that no unpublished price sensitive information (UPSI) will be shared, as the company will only reference publicly available information.
Additional Notes Section
The document is signed by Miriam Vandana, Sr. Manager (CS) of BHEL.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No financial data, guidance references, or presentation summaries were included in this announcement.
No attachments (invites, investor deck, conference schedule) were mentioned in this specific disclosure.
